The growing global burden of overweight and obesity, closely linked to dysregulated appetite and excess energy intake, has intensified interest in nutritional strategies that enhance endogenous satiety signaling via modulation of gut hormones such as CCK and glucagon-like peptide-1 (GLP-1) [3,7,8,9]. The gene discussed is GCG; the disease is obesity disorder.